Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2014

Jul 31, 2014

30016_dirs_2014-07-31_a5a8fadf-e2ec-4708-b7ea-8db2de65e98e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2014-07-30

Reporting Person: AYERS JONATHAN W (Director, Chairman, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-07-30 Common Stock M 10000 $34.3700 Acquired 406036 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-07-30 Non-Qualified Stock Option (right to buy) $34.3700 M 10000 Disposed 2016-02-13 Common Stock (10000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 49000 Indirect

Footnotes

F1: Includes 59 shares and 51 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on 03/31/2014 and 06/30/2014, respectively.

F2: Grant of options to buy shares of common stock exercisable as to 15,999 shares on each of 02/14/2010 and 02/14/2013, 16,000 shares on each of 02/14/2011 and 02/14/2012 and 13,091 shares on 02/14/2014.